myeloma

Geron Presents Interim Clinical Data on Its Telomerase Inhibitor Drug at AACR ... Read More ...

immunocellular Therapeutics Issues Letter to ShareholdersEarthtimes (press release)... the rights to investigate the potential of ICT-69 in the diagnosis and treatment of multiple myeloma (MM) and ovarian cancer for an upfront payment. ... Read More ...

Therapeutics, - ImmunoCellular Therapeutics Issues Letter to ShareholdersAd-Hoc-News (Pressemitteilung)... the rights to investigate the potential of ICT-69 in the diagnosis and treatment of multiple myeloma (MM) and ovarian cancer for an upfront payment. ... Read More ...

ImmunoCellular Therapeutics Issues Letter to ShareholdersTrading Markets (press release)... the rights to investigate the potential of ICT-69 in the diagnosis and treatment of multiple myeloma (MM) and ovarian cancer for an upfront payment. ... Read More ...

Facet Biotech Announces Four Presentations at American Society of Hematology ... Read More ...